545PClinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. (23rd October 2018) - Montagut, C; Alonso, V; Escudero, P; Fernández-Martos, C; Salud Salvia, A; Méndez, M; Gallego Plazas, J; Rodriguez, J R; Martín-Richard, M; Fernández-Plana, J; Aparicio, J; Feliu Batlle, J; et al.